Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New score aims to flag deadliest brain injuries

NCT ID NCT07816016

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

Researchers at Al-Nahrain University are developing a new clinical score called fREMS to predict the risk of dying in the hospital for patients with traumatic brain injury. The score combines the FOUR score, which measures consciousness, with physiological and clinical factors from the Rapid Emergency Medicine Score. The study will collect data from 2,000 patients to see if fREMS can accurately predict in-hospital mortality. This observational study does not test a treatment; it aims to improve early risk assessment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the fREMS score works, doctors could quickly identify which traumatic brain injury patients face the highest risk of dying in the hospital, helping guide care decisions.
What could go wrong
The score may not predict mortality accurately in different hospitals or patient groups. This observational study cannot prove that using the score improves patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consisted of adult patients (≥16 years) with acute traumatic brain injury (TBI).

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with sufficient clinical data to calculate the fREMS score, including the FOUR Score and other required physiological variables. * Patients with a documented mortality outcome . Exclusion Criteria: * Patients transferred from another hospital after initial resuscitation. * Patients who died before the required initial clinical assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TBI are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • College Of Medicine - Nahrain University

    Baghdad, Baghdad Governorate, 10011, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.